Merit Financial Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$575K Sell
19,883
-2,447
-11% -$60.1K ﹤0.01% 1493
2026
Q2
$479K Buy
+22,330
New +$342K ﹤0.01% 1522

Other funds holding ADPT

Merit Financial Group's ADPT Position: Q3 2026 in Review

Merit Financial Group reduced its Adaptive Biotechnologies (ADPT) stake by 11% in Q3 2026, selling an estimated $60.1K and leaving 19,883 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #1493.

Merit Financial Group first reported a position in ADPT in Q2 2026 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Merit Financial Group held 19,883 shares of Adaptive Biotechnologies worth $575K as of Q3 2026.
  • Merit Financial Group sold 2,447 Adaptive Biotechnologies shares in Q3 2026, an estimated $60.1K.
  • Adaptive Biotechnologies made up ﹤0.01% of Merit Financial Group's portfolio in Q3 2026, its #1493 holding.
  • Merit Financial Group first reported a position in Adaptive Biotechnologies in Q2 2026 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.